Our previous study showed that following treatment with IVIG, CD8+ T and CD4+CD29+ T cells decreased in patients with GBS, whereas CD4/CD8 and CD4+CD45RA+ T cells increased [5]. The gene discussed is ITGB1; the disease is Guillain-Barre syndrome.